Patents by Inventor Takahiro Ichi

Takahiro Ichi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11980013
    Abstract: A radio wave-absorbing laminate film in which both the top surface and the bottom surface have superior transmission attenuation properties and reflection attenuation capabilities in extremely high-frequency wave bands and higher, and which exhibits excellent radio wave absorption properties even when extremely thin; a production method for the film; and an element containing the film. A radio wave-absorbing laminate film having radio wave-absorbing layers, the radio wave-absorbing laminate film including a center layer, two substrate layers, and two radio wave-absorbing layers, the center layer containing at least one metal layer, and the two substrate layers being laminated on both surfaces of the center layer.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 7, 2024
    Assignees: The University of Tokyo, Tokyo Ohka Kogyo Co., Ltd.
    Inventors: Shin-ichi Ohkoshi, Asuka Namai, Marie Yoshikiyo, Takahiro Asai, Masaru Kuwahara
  • Patent number: 9956334
    Abstract: The present invention provides a separation membrane for blood processing, comprising a polysulfone polymer, a hydrophilic polymer and a polymer having a hydroxy group in a side chain and having a solubility of 0.5 g or less in water (100 g) at 20° C., in which the content of the polymer falls within a specific range, and a blood processing apparatus having the membrane installed therein.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: May 1, 2018
    Assignee: ASAHI KASEI MEDICAL CO., LTD.
    Inventors: Takahiro Ichi, Toshinori Koizumi
  • Patent number: 9616393
    Abstract: It is intended to provide a porous hollow fiber membrane for treating blood which suffers from little mechanical damage in the course of production, transfer or handling and shows excellent fractionation properties though it is a thinned polysulfone-based hollow fiber membrane. A porous hollow fiber membrane for treating blood which comprises a polysulfone-based polymer and polyvinylpyrrolidone and has a gradient porous structure with an increase in pore size from the inside to the outside along the membrane thickness direction, characterized in that the porous structure has a membrane thickness of 25 ?m or more but less than 40 ?m, and fibrils having an average diameter of from 100 to 200 ?m are provided in such a manner that the ratio (To/Ti) of the average outside diameter (To) along the membrane thickness direction to the average inside diameter (Ti) is adjusted to not more than 2.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: April 11, 2017
    Assignee: ASAHI KASEI MEDICAL CO., LTD.
    Inventors: Hidetoshi Hidaka, Takahiro Ichi
  • Publication number: 20150174312
    Abstract: An object of the present invention is to provide a separation membrane for blood treatment excellent in blood compatibility and reduced in elution of nitric acid ion from an inner surface even if radiation sterilization is applied in a dry state and to provide a blood treatment device having the membrane incorporated therein. The present invention provides a separation membrane for blood treatment containing at least a polysulfone resin and polyvinylpyrrolidone, wherein a proportion of intermediate water present in water in a functional separation surface of the separation membrane is 40% or more at the time when the content of water reaches a saturation point by impregnating a dry-state separation membrane with water, a water content of the separation membrane is 10% or less, and the separation membrane is subjected to radiation sterilization.
    Type: Application
    Filed: June 11, 2013
    Publication date: June 25, 2015
    Applicant: ASAHI KASEI MEDICAL CO., LTD.
    Inventors: Takahiro Ichi, Toshinori Koizumi, Makiko Hattori, Terumi Sakabe
  • Publication number: 20140284261
    Abstract: An object of the present invention is to provide a separation membrane for blood processing having high blood compatibility and storage stability and membrane performance that rarely deteriorates even if irradiation sterilization treatment is applied, and provide a blood processing apparatus having the membrane installed therein. The present invention is also directed to providing a separation membrane for blood processing having satisfactory air-bleeding during priming treatment of the blood processing membrane, and providing a blood processing apparatus having the membrane installed therein. The present invention provides a separation membrane for blood processing, comprising a polysulfone polymer, a hydrophilic polymer and a polymer having a hydroxy group in a side chain and having a solubility of 0.5 g or less in water (100 g) at 20° C., in which the content of the polymer falls within a specific range, and a blood processing apparatus having the membrane installed therein.
    Type: Application
    Filed: November 2, 2012
    Publication date: September 25, 2014
    Applicant: ASAHI KASEI MEDICAL CO., LTD.
    Inventors: Takahiro Ichi, Toshinori Koizumi
  • Patent number: 8220642
    Abstract: A polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties, excellent long-term storage stability, and a practical strength, and ensures high productivity, a polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties and long-term storage stability, rarely allows endotoxins to enter a treatment liquid, exhibits a practical strength, and ensures high productivity, and a method of producing the same. A polysulfone-based blood treatment membrane includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant, the membrane containing the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, and the total amount of the lipophilic antioxidant present on the surface of the membrane being 4 to 25 mg per gram of the membrane.
    Type: Grant
    Filed: May 26, 2008
    Date of Patent: July 17, 2012
    Assignee: Asahi Kasei Medical Co., Ltd.
    Inventors: Junya Satoh, Takahiro Ichi, Shunji Maniwa
  • Publication number: 20100258496
    Abstract: It is intended to provide a porous hollow fiber membrane for treating blood which suffers from little mechanical damage in the course of production, transfer or handling and shows excellent fractionation properties though it is a thinned polysulfone-based hollow fiber membrane. A porous hollow fiber membrane for treating blood which comprises a polysulfone-based polymer and polyvinylpyrrolidone and has a gradient porous structure with an increase in pore size from the inside to the outside along the membrane thickness direction, characterized in that the porous structure has a membrane thickness of 25 ?m or more but less than 40 ?m, and fibrils having an average diameter of from 100 to 200 ?m are provided in such a manner that the ratio (To/Ti) of the average outside diameter (To) along the membrane thickness direction to the average inside diameter (Ti) is adjusted to not more than 2.
    Type: Application
    Filed: December 4, 2008
    Publication date: October 14, 2010
    Applicant: ASAHI KASEI KURARAY MEDICAL CO., LTD.
    Inventors: Hidetoshi Hidaka, Takahiro Ichi
  • Publication number: 20100133170
    Abstract: A polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties, excellent long-term storage stability, and a practical strength, and ensures high productivity, a polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties and long-term storage stability, rarely allows endotoxins to enter a treatment liquid, exhibits a practical strength, and ensures high productivity, and a method of producing the same. A polysulfone-based blood treatment membrane includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant, the membrane containing the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, and the total amount of the lipophilic antioxidant present on the surface of the membrane being 4 to 25 mg per gram of the membrane.
    Type: Application
    Filed: May 26, 2008
    Publication date: June 3, 2010
    Applicant: ASAHI KASEI KURARAY MEDICAL CO., LTD.
    Inventors: Junya Satoh, Takahiro Ichi, Shunji Maniwa